share_log

Demystifying Select Medical Hldgs: Insights From 4 Analyst Reviews

Demystifying Select Medical Hldgs: Insights From 4 Analyst Reviews

分析師對醫療控股公司Select Medical進行了4次評估,揭示了更多信息。
Benzinga ·  08/02 14:02
Throughout the last three months, 4 analysts have evaluated Select Medical Hldgs (NYSE:SEM), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中,有4位分析師對Select Medical Hldgs(紐約證券交易所代碼:SEM)進行了評估,提供了從看漲到看跌的不同觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級,展示了過去30天內不斷變化的情緒,並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $44.5, a high estimate of $48.00, and a low estimate of $40.00. This upward trend is apparent, with the current average reflecting a 7.88% increase from the previous average price target of $41.25.
分析師評估的12個月目標股價揭示了進一步的見解,平均目標價爲44.5美元,最高估計爲48.00美元,低估值爲40.00美元。這種上升趨勢顯而易見,當前的平均價格較之前的平均目標價41.25美元上漲了7.88%。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級:全面細分
The perception of Select Medical Hldgs...
通過分析師最...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論